AU458386B2 - Improvements in or relating tothe treatment of diseases ofthe skin and mucosa - Google Patents

Improvements in or relating tothe treatment of diseases ofthe skin and mucosa

Info

Publication number
AU458386B2
AU458386B2 AU38242/72A AU3824272A AU458386B2 AU 458386 B2 AU458386 B2 AU 458386B2 AU 38242/72 A AU38242/72 A AU 38242/72A AU 3824272 A AU3824272 A AU 3824272A AU 458386 B2 AU458386 B2 AU 458386B2
Authority
AU
Australia
Prior art keywords
mucosa
relating tothe
ofthe skin
diseases ofthe
tothe treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU38242/72A
Other languages
English (en)
Other versions
AU3824272A (en
Inventor
Collin Michael
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COMPREHENSIVE PHARMACEUTICALS Ltd
Original Assignee
COMPREHENSIVE PHARMACEUTICALS Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COMPREHENSIVE PHARMACEUTICALS Ltd filed Critical COMPREHENSIVE PHARMACEUTICALS Ltd
Publication of AU3824272A publication Critical patent/AU3824272A/en
Application granted granted Critical
Publication of AU458386B2 publication Critical patent/AU458386B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU38242/72A 1971-01-22 1972-01-24 Improvements in or relating tothe treatment of diseases ofthe skin and mucosa Expired AU458386B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10901771A 1971-01-22 1971-01-22
USUS109,017 1971-01-22

Publications (2)

Publication Number Publication Date
AU3824272A AU3824272A (en) 1973-07-26
AU458386B2 true AU458386B2 (en) 1975-02-10

Family

ID=22325363

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38242/72A Expired AU458386B2 (en) 1971-01-22 1972-01-24 Improvements in or relating tothe treatment of diseases ofthe skin and mucosa

Country Status (8)

Country Link
AU (1) AU458386B2 (cs)
BE (1) BE778334A (cs)
CA (1) CA963388A (cs)
DE (1) DE2202964A1 (cs)
FR (1) FR2122613B2 (cs)
GB (1) GB1368201A (cs)
IE (1) IE35991B1 (cs)
ZA (1) ZA72423B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59002748D1 (de) * 1990-01-29 1993-10-21 Wogepharm Gmbh Verfahren zur Herstellung von Mitteln zur Therapie von Hauterkrankungen.
HU212426B (en) * 1992-07-22 1996-06-28 Vepex Kft Process for producing bioactive pharmaceutical compositions
WO1994022421A2 (de) * 1993-04-02 1994-10-13 Wogepharm Gmbh Verwendung von wasserlöslichen magnesiumsalzen in äusserlich anzuwendenden zubereitungen und neue kombinationspräparate
WO1996019183A1 (en) * 1994-12-21 1996-06-27 Cosmederm Technologies Formulations and methods for reducing skin irritation
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
AU4606496A (en) * 1994-12-21 1996-07-10 Cosmederm Technologies Formulations and methods for reducing skin irritation
FR2732601B1 (fr) * 1995-04-10 1997-05-09 Oreal Utilisation d'un sel de metal alcalino-terreux pour le traitement des rougeurs cutanees d'origine neurogene
FR2732599B1 (fr) * 1995-04-10 1997-05-16 Oreal Utilisation de sels de metaux alcalino-terreux comme inhibiteurs de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
EP0737471A3 (fr) * 1995-04-10 2000-12-06 L'oreal Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue
FR2732602B1 (fr) * 1995-04-10 1997-05-09 Oreal Utilisation d'un sel d'un metal alcalino-terreux dans une composition cosmetique ou pharmaceutique pour traiter les prurits
FR2732600B1 (fr) * 1995-04-10 1997-05-09 Oreal Utilisation d'un sel d'un metal alcalino-terreux dans une composition cosmetique et/ou dermatologique et composition obtenue
FR2740335B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p
FR2740341B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau
EP4014962A1 (de) * 2020-12-16 2022-06-22 Novigo GmbH & Co. KG Zusammensetzung mit osmotisch wirksamer substanz und verwendung der zusammensetzung

Also Published As

Publication number Publication date
AU3824272A (en) 1973-07-26
IE35991L (en) 1972-07-22
FR2122613B2 (cs) 1975-08-01
FR2122613A2 (cs) 1972-09-01
CA963388A (en) 1975-02-25
GB1368201A (en) 1974-09-25
ZA72423B (en) 1972-10-25
BE778334A (fr) 1972-05-16
DE2202964A1 (de) 1972-08-10
IE35991B1 (en) 1976-07-21

Similar Documents

Publication Publication Date Title
AU458386B2 (en) Improvements in or relating tothe treatment of diseases ofthe skin and mucosa
IL37098A0 (en) Skin treatment composition and its preparation
AU465568B2 (en) Improvement in or relating to methods of seed treatment and apparatus therefor
AU465949B2 (en) N-TERTIARY-4'-AMINOMETHYL-DIBENZO b,e-11-OXEPINE-2'-SPIRO-1',3'-DIOXOLANES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTIC APPLICATION
ZA711442B (en) Improvements in and relating to the treatment of titanium dioxide pigments
AU471474B2 (en) Method and compositions forthe treatment of human hair
IL42108A (en) The preparation of human acth and its fragments
AU458749B2 (en) Process for the treatment and care of dentures
AU464446B2 (en) Improvements in and relating to apparatus for the treatment of pigments
CA1000714A (en) Diuretics and agents useful in the treatment of hyperaidosteronism
ZA724296B (en) New medicants for the treatment of excess lipidic and cellulitic stresses
AU461236B2 (en) Combination of l-dops and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinson's disease
AU479644B2 (en) Improvements in and relating tothe treatment of pigments
CA837050A (en) Method of and composition for the treatment of human carcinoma and hypercholestrolemia
AU4797772A (en) Improvements in and relating tothe treatment of pigments
AU454866B2 (en) Improvements in and relating tothe treatment of oxide pigments
CA989731A (en) Treatment of heart diseases
CA919686A (en) Prophylaxis and treatment of cardiac disorders
AU457333B2 (en) Improvements in and relating tothe treatment of titanium dioxide pigments
AU436510B2 (en) Improvements in and relating tothe treatment of titanium dioxide pigments
AU2434371A (en) Improvements in and relating tothe treatment of oxide pigments
AU456744B2 (en) Improvements in and relating to the treatment of titanium dioxide pigments
AU423068B2 (en) Prophylaxis and treatment of cardiac disorders
AU2581471A (en) Improvements in and relating tothe treatment of titanium dioxide pigments
AU1022770A (en) Improvements in and relating tothe treatment of titanium dioxide pigments